Lesion stratification with intracoronary imaging.

Journal: EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology
Published Date:

Abstract

Intracoronary (IC) imaging-guided percutaneous coronary intervention (PCI) improves clinical outcomes in patients with high clinical and anatomical risk when compared to interventions guided by angiography alone. Recent Class I recommendations for the use of IC imaging guidance when performing PCI in left main stem or complex lesions may result in a significant uptake as the technology is embraced as standard of care. Routine application of IC imaging will provide interventional cardiologists with a wealth of high-fidelity intracoronary data on plaque composition and distribution. When paired with emerging data regarding the importance of plaque anatomical characteristics, developments in artificial intelligence and computational fluid dynamics, lesion stratification with IC imaging may herald the next paradigm shift in this field. In this review, we will explore this important emerging application of IC imaging to inform morphology-guided PCI, identify high-risk lesions for targeted therapies, and consider the prospects of harnessing automated image interpretation with artificial intelligence technologies to achieve an integrated physiological and morphological assessment. Lesion stratification with IC imaging has the potential to shape the future of interventional cardiology practice to guide therapies within and beyond the confines of the cardiac catheterisation laboratory.

Authors

  • Michael McGarvey
    Department of Cardiology, King's College Hospital NHS Foundation Trust, London, United Kingdom.
  • Kalpa De Silva
    BHF Centre of Excellence, School of Cardiovascular and Metabolic Medicine & Sciences, King's College London, London, United Kingdom.
  • Thomas R Keeble
    Essex Cardiothoracic Centre, Mid and South Essex NHS Foundation Trust, Basildon, United Kingdom.
  • Thomas W Johnson
    Bristol Heart Institute, University Hospitals Bristol NHS FT & University of Bristol, Bristol, United Kingdom.
  • Peter O'Kane
    University Hospital Dorset NHS Trust, Bournemouth, UK.
  • Ziad A Ali
    DeMatteis Cardiovascular Institute, St. Francis Hospital and Heart Center, Cardiovascular Research Foundation, 100 Port Washington Blvd, Roslyn, NY, 11576, USA.
  • Shengxian Tu
    Biomedical Instrument Institute, School of Biomedical Engineering, Shanghai Jiao Tong University.
  • Sundeep Kalra
    Department of Cardiology, Royal Free NHS Foundation Trust, London, United Kingdom.
  • Divaka Perera
    BHF Centre of Excellence, School of Cardiovascular and Metabolic Medicine & Sciences, King's College London, London, United Kingdom.
  • Philip MacCarthy
    Department of Cardiology, King's College Hospital NHS Foundation Trust, London, United Kingdom.
  • Jonathan M Hill
    Royal Brompton Hospital, London, UK.
  • Jonathan Byrne
    Department of Cardiology, King's College Hospital NHS Foundation Trust, London, United Kingdom.
  • Rafal Dworakowski
    Department of Cardiology, King's College Hospital NHS Foundation Trust, London, United Kingdom.
  • Nilesh Pareek
    Department of Cardiology, King's College Hospital NHS Foundation Trust, London, United Kingdom.